Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
883 USD | -0.86% | -1.48% | +0.60% |
06:25pm | Regeneron Faces Q1 Seasonality Despite Eylea HD Launch, Oppenheimer Says | MT |
02:45pm | Oppenheimer Adjusts Price Target on Regeneron Pharmaceuticals to $1,175 From $1,125 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.60% | 95.71B | |
-2.29% | 103B | |
+1.69% | 22.02B | |
-17.41% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.94% | 15.52B | |
+3.15% | 13.86B | |
+33.78% | 12.04B | |
-24.76% | 8.08B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Baird Adjusts Regeneron Pharmaceuticals Price Target to $800 From $756, Maintains Neutral Rating